விளக்கப்படங்கள் நுரையீரல் மதிப்பீடு அமைப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Confirm REDWOOD CITY, Calif., May 04, 2021 (GLOBE NEWSWIRE) Pulmonx Corporation ( LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the appointment of Michael Ryan as Vice President, Corporate Strategy and Business Development, and the earlier appointments of David Lehman as General Counsel, and Mahtab Fatemi as Vice President, Regulatory Affairs and Quality Assurance. “We could not be more excited to have these three deeply experienced professionals on the Pulmonx team. Each of these individuals is uniquely qualified and brings a wealth of insight and knowledge about the medical device business to their respective areas of responsibility,” said Glen French, President and CEO of Pulmonx. 

Santa clara universityUnited statesMeghan oresteBrian johnstonPulmonxs zephyr endobronchialBoston scientific corporationRegulatory affairsThoratec corporationCornell universityMarketing communicationsGeorgetown universityGilmartin groupUniversity of california at san diegoCornell law schoolMuir collegePulmonx corporation